Lucas123 writes: In a report released today, Gartner predicts that the time is drawing near when 3D-bioprinted human organs will be readily available, an advance almost certain to spark a complex debate involving a variety of political, moral and financial interests. For example, some researchers are using cells from human and non-human organs to create stronger tissue, said Pete Basiliere, a Gartner research director. "In this example, there was human amniotic fluid, canine smooth muscle cells, and bovine cells all being used. Some may feel those constructs are of concern," he said. While regulations in the U.S. and Europe will mean human trials of 3D printed organs will likely take up to a decade, nations with less stringent standards will plow ahead with the technology. For example, last August, the Hangzhou Dianzi University in China announced it had invented the biomaterial 3D printer Regenovo, which printed a small working kidney that lasted four months. Apart from printing tissue, 3D printing may also threaten intellectual property rights. "IP will be ignored and it will be impossible or impractical to enforce. Everything will change when you can make anything." said John Hornick, an IP attorney with Finnegan, Henderson, Farbow, Garrett & Dunner LLP in New York.